CompanyDrug

Hengrui Pharmaceuticals Gets NMPA Green Light for Phase Ib/II Study of SHR-A1921 Combo in Advanced Solid Tumors

CompanyDeals

Biocytogen Strikes Exclusive Licensing Deal with US-Based Radiance Biopharma for Innovative BsADC

CompanyDrug

MSD Advances Four Oncology Candidates to Late-Stage Trials, Including Partnerships with Kelun-Biotech and Orion

CompanyDeals

AstraZeneca Secures Exclusive Rights to Omniose’s Enzyme Platform for Bacterial Vaccine Development

CompanyPolicy / Regulatory

China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024

CompanyDeals

AbbVie Partners with Umoja Biopharma to Develop Next-Generation CAR-T Therapies

CompanyDeals

Weigao Blood Purification Aims for USD 190 Million in Shanghai Stock Exchange IPO

CompanyDrug

BMS’s Abraxane Approved in China for First-Line Metastatic Pancreatic Cancer Treatment

CompanyDeals

Bayer AG Leads Series D Investment in Jixing Pharmaceuticals, Eyeing Commercialization Rights

Policy / Regulatory

China’s NMPA Issues Guidelines for Inspection of Third-Party Online Drug Trading Platforms

CompanyDeals

Novartis Strikes Deal with Argo Biopharma for Global Rights to siRNA Drug Candidates

CompanyDeals

Novartis to Fully Acquire SanReno Therapeutics to Expand Kidney Drug Portfolio in China